Skip to main content
FinSpry Logo
FinSpry
MDXG logo
MDXG
(NASDAQ)
MiMedx Group, Inc.
$4.33-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

MiMedx Group (MDXG) Stock Price & Financial Analysis

MiMedx Group Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.18 - $4.28
52-Week High$7.97
52-Week Low$3.03
Open$4.26
Volume898.51K
Average Volume (3M)1.37M
Market Cap619.26M
Shares Outstanding147.80M
P/E Ratio (TTM)99.29
Forward P/E200.00
Price to Sales (P/S)1.74
Price to Book (P/B)2.87
EV/EBITDA23.25
Revenue (TTM)355.17M
Net Income (TTM)6.24M
Free Cash Flow (TTM)40.69M
EPS (TTM)$0.04
Profit Margin1.76%
Operating Margin2.46%
Return on Equity (ROE)2.89%
Debt to Equity0.08
50-Day MA$4.05
200-Day MA$4.92
52-Week Change-41.07%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About MiMedx Group

What is the current stock price for MDXG?

As of the latest trading session, MDXG stock trades at $4.19. The 52-week range is $3.03–$7.97, with a day range of $4.17–$4.28.

What is the P/E ratio for MDXG?

MiMedx Group's trailing P/E ratio is 99.3, meaning investors pay $99.3 for every $1 of annual earnings. The forward P/E is 200.0, reflecting analyst expectations for future earnings. MiMedx Group operates in the Healthcare sector.

Does MDXG pay dividends?

MiMedx Group does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MDXG?

Based on 2 analysts, the consensus for MDXG is Buy.

What is the market cap of MDXG?

MiMedx Group's market capitalization is $619.3M, classifying it as a small-cap company. MiMedx Group operates in the Healthcare sector within the Biotechnology industry.